Loading…
Strata Critical Medical, Inc. is projected to rise to $6.51 by 2027, a +27% move from its current price of $5.11. SRTA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $5.00 | $5.11 | $5.23 | +0.02% |
| Jul 15 | $4.95 | $5.11 | $5.28 | +0.04% |
| Jul 16 | $4.92 | $5.11 | $5.32 | +0.06% |
| Jul 17 | $4.89 | $5.11 | $5.35 | +0.08% |
| Jul 18 | $4.86 | $5.11 | $5.38 | +0.10% |
| Jul 19 | $4.84 | $5.12 | $5.41 | +0.11% |
| Jul 20 | $4.82 | $5.12 | $5.43 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.82 | $5.12 | $5.43 | +0.13% |
| Week 2 | $4.71 | $5.12 | $5.58 | +0.27% |
| Week 3 | $4.62 | $5.13 | $5.69 | +0.40% |
| Week 4 | $4.55 | $5.14 | $5.79 | +0.54% |
| Week 5 | $4.50 | $5.14 | $5.89 | +0.67% |
| Week 6 | $4.45 | $5.15 | $5.97 | +0.81% |
| Week 7 | $4.40 | $5.16 | $6.05 | +0.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Strata Critical Medical, Inc. operates in the Healthcare sector in the United States. It provides time-critical logistics and medical services to the healthcare industry.
The company runs two segments, Logistics and Clinical, offering services such as air and ground transportation for human organs, transplant teams, and related organ placement services; transplant clinical services including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals.
The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. It was founded in 2014 and is headquartered in New York, New York. The asset is categorized in Healthcare.
SRTA is currently priced at $5.18 per share, with a market capitalization of $448.21M and a rank of 2980.
The price outlook for 2026 shows an average price of $5.18, with a min of $4.04 and a max of $6.49; the forecast sentiment is Neutral and the ROI is 0% for that year.
From 2027 onward, the forecast turns bullish, with rising averages and meaningful ROI: 2027 avg $6.67, ROI 28.8%; 2028 avg $8.25, ROI 59.3%; 2029 avg $9.79, ROI 89%; 2030 avg $11.03, ROI 112.9%.
The longer-horizon outlook continues to show strong upside, including 2031 avg $11.01, 2032 avg $12.63, 2033 avg $14.12, 2034 avg $15.45, 2035 avg $19.69, 2040 avg $26.68 (ROI 415), and 2050 avg $58.02 (ROI 1020).
A major floor 20.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 26.6% above — a clean break opens room to run.
A major ceiling 35.5% above — clearing it would confirm fresh momentum.
Key SRTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SRTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.22 | Sell | $5.19 | Sell |
| MA 10 | $5.25 | Sell | $5.27 | Sell |
| MA 20 | $5.45 | Sell | $5.40 | Sell |
| MA 50 | $5.56 | Sell | $5.40 | Sell |
| MA 100 | $5.01 | Buy | $5.21 | Sell |
| MA 200 | $4.99 | Buy | $4.93 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.29 | Neutral |
| Stoch RSI (14) | 0.10 | Buy |
| CCI (20) | -108.00 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -8.26 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.23 | Sell |
| Awesome (5,34) | -0.48 | Sell |
| Ultimate (7,14,28) | 29.79 | Buy |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 5.11 | Sell |
| ADX (14) | 16.82 | Neutral |
| ATR (14) | 0.11 | Info |
The 30-day technical picture is bullish overall. The RSI(14) is 40, and the price indices show the SMA50 at $5.49 and the SMA200 at $4.98.
The 30-day price range runs from a low of $4.35 to a high of $6.17. Support is noted at $5.18 and resistance at $6.47, with annualized volatility around 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.04 | $5.11 | $6.33 | 0% | Neutral | |
| $5.26 | $6.51 | $8.47 | +27% | Bullish | |
| $6.31 | $7.98 | $10.71 | +56% | Bullish | |
| $7.28 | $9.38 | $12.91 | +84% | Bullish | |
| $8.15 | $10.68 | $15.01 | +109% | Bullish | |
| $8.15 | $10.85 | $15.53 | +112% | Bullish | |
| $9.05 | $12.22 | $17.78 | +139% | Bullish | |
| $10.10 | $13.81 | $20.40 | +170% | Bullish | |
| $10.98 | $15.20 | $22.76 | +197% | Bullish | |
| $13.31 | $18.64 | $28.27 | +265% | Bullish | |
| $17.69 | $26.12 | $41.82 | +411% | Bullish | |
| $34.52 | $55.76 | $96.66 | +991% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.04 | $5.11 | $6.04 | +0.00% |
| August 2026 | $4.31 | $5.06 | $6.09 | -0.91% |
| September 2026 | $4.40 | $5.20 | $6.32 | +2.70% |
| October 2026 | $4.42 | $5.24 | $6.42 | +0.86% |
| November 2026 | $4.28 | $5.11 | $6.29 | -2.64% |
| December 2026 | $4.26 | $5.10 | $6.33 | -0.07% |
Click any year to see its month-by-month SRTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SRTA to range from $4.04 to $6.33 through 2026. The $5.11 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SRTA price prediction for 2027 points to an average of $6.51 (low $5.26, high $8.47) — a potential gain of +27% on today's $5.11. Momentum favours further upside here.
In 2028, SRTA is projected to trade between $6.31 and $10.71, averaging $7.98 — a potential gain of +56% from today's $5.11. That is up +23% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Strata Critical Medical, Inc.'s 2029 outlook centres on $9.38, within a $7.28 to $12.91 range. That is up +18% on the projected 2028 average. That marks a +84% change versus current levels. Momentum favours further upside here.
By 2030, SRTA could reach as high as $15.01, with a base case around $10.68 and support toward $8.15 — roughly +109% from $5.11. Buyers look set to stay in control over this stretch.
Expect SRTA to range from $8.15 to $15.53 through 2031. The $10.85 average target implies a +112% move from current prices. That is up +2% on the projected 2030 average. Momentum favours further upside here.
The SRTA price prediction for 2032 points to an average of $12.22 (low $9.05, high $17.78) — a potential gain of +139% on today's $5.11. Buyers look set to stay in control over this stretch.
In 2033, SRTA is projected to trade between $10.10 and $20.40, averaging $13.81 — a potential gain of +170% from today's $5.11. That is up +13% on the projected 2032 average. Momentum favours further upside here.
Strata Critical Medical, Inc.'s 2034 outlook centres on $15.20, within a $10.98 to $22.76 range. That is up +10% on the projected 2033 average. That marks a +197% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, SRTA could reach as high as $28.27, with a base case around $18.64 and support toward $13.31 — roughly +265% from $5.11. Momentum favours further upside here.
Expect SRTA to range from $17.69 to $41.82 through 2040. The $26.12 average target implies a +411% move from current prices. That is up +40% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SRTA price prediction for 2050 points to an average of $55.76 (low $34.52, high $96.66) — a potential gain of +991% on today's $5.11. Momentum favours further upside here.
Investing $1,000 in SRTA today (≈ 195.694716 SRTA) could be worth
$10,912.3
+$9,912.3 (+991%) by 2050 · US Dollar
Based on the average projected SRTA price of $55.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SRTAwould be worth at today's price.
$1,000 invested in SRTA on Jul 10, 2025 (≈ 235.294118 SRTA) would be worth
$1,202.35
+$202.35 (+20.2%) today · 1.20× · US Dollar
Based on a SRTA entry price of $4.25 vs. today's $5.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.41 | $944.55 | -5.5% |
| 1 month ago | $5.48 | $932.48 | -6.8% |
| 3 months ago | $4.04 | $1,264.85 | +26.5% |
| 6 months ago | $5.79 | $882.56 | -11.7% |
| 1 year ago | $4.25 | $1,202.35 | +20.2% |
| All time (5.0y) ago | $8.05 | $634.78 | -36.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SRTA forecast.
Our base-case forecast reaches $10.00 around 2030.
Implied market cap at $10.00: $865.27M
The multi-year forecast points to sustained bullish sentiment through the next years, with rising price averages and expanding ROI. In 2030 the average price is forecast at $11.03 with a ROI of 112.9 and a bullish sentiment, indicating meaningful upside from current levels.
Forecasts for 2040 show an average of $26.68 with a ROI of 415 and a bullish stance, suggesting substantial appreciation potential if the trajectory continues. By 2050 the average is $58.02 with a ROI of 1020, again with bullish sentiment, indicating a high upside scenario over the long term.
These figures are estimates and not guarantees; there is uncertainty and risk in any forecast, and outcomes can vary with market conditions and other factors.
Tap a question to reveal the answer.
2030 avg $11.03, min $8.21, max $15.96; ROI 112.9; sentiment bullish.
Forecasts show bullish sentiment from 2027 onward with rising averages and positive ROI; for example 2027 avg $6.67 and ROI 28.8, 2028 avg $8.25 and ROI 59.3, 2029 avg $9.79 and ROI 89.
Yes, the max forecast by 2050 is $106.23, which crosses $100.
30-day range low $4.35, high $6.17.
Current price $5.18; market cap $448.21M.
Strata Critical Medical, Inc. Community Discussion
0Share your Strata Critical Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.